P. Arapantoni

HER2 and TOP2A in high-risk early breast cancer patients treated with adjuvant epirubicin-based dose-dense sequential chemotherapy

George Fountzilas, Christos Valavanis, Vassiliki Kotoula et al. · Journal of Translational Medicine · 2012 · 100 citations · Full text

Medicine, Oncology, Pharmacology +17

FT-IR microimaging spectroscopy: A comparison between healthy and neoplastic human colon tissues

P. Ferraris, Elisabetta Giorgini, Corrado Rubini et al. · Journal of Molecular Structure · 2007 · 42 citations · Full text

Natural Sciences, Chemistry, Oncology +14

Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group (HeCOG) randomized phase III trial

Pantelis Skarlos, C. Christodoulou, Konstantine T. Kalogeras et al. · Cancer Chemotherapy and Pharmacology · 2011 · 25 citations

Medicine, Oncology, Chemotherapy +15

Survivin and glycodelin transcriptional activity in node-positive early breast cancer: mRNA expression of two key regulators of cell survival

L. Kostadima, George Pentheroudakis, George Fountzilas et al. · Breast Cancer Research and Treatment · 2006 · 20 citations

Medicine, Molecular Biology, Oncology +11

Immunoscintigraphy with131I-labelled HMFG2 and HMFG2 F(ab')2 in the pre-operative detection of clinical and subclinical lymph node metastases in breast cancer patients

A. Athanassiou, Dimitrios Pectasides, K. Pateniotis et al. · International Journal of Cancer · 1988 · 20 citations

Medicine, Nuclear Medicine, Radiology +15